100K naloxone doses ease national shortage

To combat the opioid epidemic, nonprofit Remedy Alliance bought 100,000 doses of naloxone, a drug that’s used to reverse opioid overdoses, and community groups have already ordered 43,000 doses, according to The Washington Post.

Advertisement

Because states don’t have enough of the opioid overdose antidote, Remedy Alliance negotiates with naloxone manufacturers to lower prices and then sells it to community groups and local governments. The organization formed in 2008 as the Opioid Safety and Naloxone Network Buyers Club. 

Remedy Alliance is responsible for “a substantial portion” of the nation’s naloxone supply, Susan Winckler, the CEO of the FDA’s Reagan-Udall Foundation, told the Post. 

Between 2017 and 2021, the nonprofit sold more than 4 million doses, according to its website. 

“The affordable naloxone shortage is officially over,” Remedy Alliance’s organizers told the Post.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

  • Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

  • As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

Advertisement

Comments are closed.